(Q51581819)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612854%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

title

Can metformin reduce insulin resistance in polycystic ovary syndrome? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612854%20AND%20SRC:MED&resulttype=core&format=json

polycystic ovary syndrome

15 October 2019

main subject

1 reference

1 reference

1 reference

1 reference

1 reference

O Açbay

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612854%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

S Gündoğdu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612854%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

language of work or name

English

0 references

publication date

1 May 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612854%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

published in

Fertility and Sterility

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612854%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612854%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612854%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

946-949

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612854%20AND%20SRC:MED&resulttype=core&format=json

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

15 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2958266-1

Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2958266-1

Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2958266-1

Lipid and apolipoprotein abnormalities in hirsute women. I. The association with insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2958266-1

Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2958266-1

Persistence of insulin resistance in polycystic ovarian disease after inhibition of ovarian steroid secretion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2958266-1

Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2958266-1

Distribution and characterization of insulin and insulin-like growth factor I receptors in normal human ovary.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2958266-1

Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2958266-1

Validation of the low dose short insulin tolerance test for evaluation of insulin sensitivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2958266-1

Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2958266-1

Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2958266-1

Association of Metformin's Effect to Increase Insulin-Stimulated Glucose Transport With Potentiation of Insulin-Induced Translocation of Glucose Transporters From Intracellular Pool to Plasma Membrane in Rat Adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2958266-1

Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2958266-1

Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2958266-1

The influence of androgens on insulin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2958266-1

The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2958266-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0015-0282(16)58266-1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612854%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference